There is no short, yes/no answer to that question, because many of the communicable, deadly diseases are spread by simply being in society, NOT by sexual contact as is the case with human papilloma virus!

There are many diseases spread by physical or sexual contact besides HPV, such as HIV and hepatitis. If you want the government to mandate HPV vaccinations for everyone, are you going to push for everyone getting hepatitis shots too?

When diseases that are airborne are on the loose and epidemic, I think it's appropriate to require it.

Here is a great example that is not even being talked about, while Guardasil against HPV is being talked about....I think because Hollywood and their politicians have succeeded in training people to think that....

Sexual freedom without giving disease a thought is what matters most. Meanwhile, this is a big problem:

"Europe is facing a wave of drug-resistant TB, the World Health Organization (WHO) reported.

The United Nations agency has launched a five-year plan to contain what is said is an "alarming problem" – the region, mainly eastern Europe, bears more than 18% of the global burden of multidrug-resistant TB (MDR-TB).
The toll of extensively drug-resistant TB (XDR-TB) is harder to quantify, the agency said, because many European countries do not have the technical resources to identify cases. But despite that, the number of reported cases recently nearly tripled – from 132 in 2008 to 344 in 2009.

"TB is an old disease that never went away, and now it is evolving with a vengeance," Zsuzsanna Jakab, WHO Regional Director for Europe, said in a statement........

...Currently, the WHO said in a report outlining its five-year plan, there are an estimated 81,000 cases of MDR-TB in the European region, out of a world total estimate of 440,000. The numbers are estimates because in many places formal resistance surveys have never been performed.

And in Europe, the WHO reported, only about a third of the estimated 81,000 cases have been formally reported to health agencies – 27,760 or 34.2% -- mainly because of a lack of drug susceptibility testing or more modern molecular diagnostic methods.

Of those, only 17,169 patients, or 61.8%, were reported to be getting adequate treatment with second-line drugs.

Diagnosing XDR-TB requires the ability to test for susceptibility to second-line drugs, ........

.....The British capital of London has 3,500 cases of TB a year – the highest rate of any western European capital -- and 2% of those are MDR-TB, according to the Stop TB Partnership, an international coalition of organizations aimed at curbing TB........

........Those countries must also examine their health systems, raise awareness of the problem among clinicians, and adopt action plans to deal with the issue, the agency said. The plan also calls for an uninterrupted supply of quality first- and second-line drugs in all countries by the end of 2013........"
http://www.medpagetoday.com/Infectio...rculosis/28503